218 related articles for article (PubMed ID: 9700205)
1. Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA.
McCarthy EM; Phillips JA
Hum Mol Genet; 1998 Sep; 7(9):1491-6. PubMed ID: 9700205
[TBL] [Abstract][Full Text] [Related]
2. A novel mechanism of aberrant pre-mRNA splicing in humans.
Cogan JD; Prince MA; Lekhakula S; Bundey S; Futrakul A; McCarthy EM; Phillips JA
Hum Mol Genet; 1997 Jun; 6(6):909-12. PubMed ID: 9175738
[TBL] [Abstract][Full Text] [Related]
3. An exon splice enhancer mutation causes autosomal dominant GH deficiency.
Moseley CT; Mullis PE; Prince MA; Phillips JA
J Clin Endocrinol Metab; 2002 Feb; 87(2):847-52. PubMed ID: 11836331
[TBL] [Abstract][Full Text] [Related]
4. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene.
Nishiyama T; Hatano H; Kurosaka M; Bolander ME; Sarkar G
J Bone Miner Res; 2003 Sep; 18(9):1716-22. PubMed ID: 12968682
[TBL] [Abstract][Full Text] [Related]
5. GH1 splicing is regulated by multiple enhancers whose mutation produces a dominant-negative GH isoform that can be degraded by allele-specific small interfering RNA (siRNA).
Ryther RC; Flynt AS; Harris BD; Phillips JA; Patton JG
Endocrinology; 2004 Jun; 145(6):2988-96. PubMed ID: 14988388
[TBL] [Abstract][Full Text] [Related]
6. An intron splicing enhancer containing a G-rich repeat facilitates inclusion of a vertebrate micro-exon.
Carlo T; Sterner DA; Berget SM
RNA; 1996 Apr; 2(4):342-53. PubMed ID: 8634915
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms responsible for dominant expression of human growth hormone gene mutations.
Binder G; Brown M; Parks JS
J Clin Endocrinol Metab; 1996 Nov; 81(11):4047-50. PubMed ID: 8923859
[TBL] [Abstract][Full Text] [Related]
8. A novel deletion in the GH1 gene including the IVS3 branch site responsible for autosomal dominant isolated growth hormone deficiency.
Vivenza D; Guazzarotti L; Godi M; Frasca D; di Natale B; Momigliano-Richiardi P; Bona G; Giordano M
J Clin Endocrinol Metab; 2006 Mar; 91(3):980-6. PubMed ID: 16368751
[TBL] [Abstract][Full Text] [Related]
9. A novel IVS2 -2A>T splicing mutation in the GH-1 gene in familial isolated growth hormone deficiency type II in the spectrum of other splicing mutations in the Russian population.
Fofanova OV; Evgrafov OV; Polyakov AV; Poltaraus AB; Peterkova VA; Dedov II
J Clin Endocrinol Metab; 2003 Feb; 88(2):820-6. PubMed ID: 12574219
[TBL] [Abstract][Full Text] [Related]
10. A novel and de novo splice-donor site mutation in intron 3 of the GH-1 gene in a patient with isolated growth hormone deficiency.
Katsumata N; Matsuo S; Sato N; Tanaka T
Growth Horm IGF Res; 2001 Dec; 11(6):378-83. PubMed ID: 11914025
[TBL] [Abstract][Full Text] [Related]
11. Identification of intron and exon sequences involved in alternative splicing of insulin receptor pre-mRNA.
Kosaki A; Nelson J; Webster NJ
J Biol Chem; 1998 Apr; 273(17):10331-7. PubMed ID: 9553088
[TBL] [Abstract][Full Text] [Related]
12. Isolated autosomal dominant growth hormone deficiency: stimulating mutant GH-1 gene expression drives GH-1 splice-site selection, cell proliferation, and apoptosis.
Salemi S; Yousefi S; Lochmatter D; Eblé A; Deladoëy J; Robinson IC; Simon HU; Mullis PE
Endocrinology; 2007 Jan; 148(1):45-53. PubMed ID: 17038549
[TBL] [Abstract][Full Text] [Related]
13. An intron enhancer containing a 5' splice site sequence in the human calcitonin/calcitonin gene-related peptide gene.
Lou H; Yang Y; Cote GJ; Berget SM; Gagel RF
Mol Cell Biol; 1995 Dec; 15(12):7135-42. PubMed ID: 8524281
[TBL] [Abstract][Full Text] [Related]
14. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
Hovhannisyan RH; Carstens RP
Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
[TBL] [Abstract][Full Text] [Related]
15. Modulation of in vitro splicing of the upstream intron by modifying an intra-exon sequence which is deleted from the dystrophin gene in dystrophin Kobe.
Takeshima Y; Nishio H; Sakamoto H; Nakamura H; Matsuo M
J Clin Invest; 1995 Feb; 95(2):515-20. PubMed ID: 7860733
[TBL] [Abstract][Full Text] [Related]
16. Two different 5' splice site mutations in the growth hormone gene causing autosomal dominant growth hormone deficiency.
Missarelli C; Herrera L; Mericq V; Carvallo P
Hum Genet; 1997 Nov; 101(1):113-7. PubMed ID: 9385381
[TBL] [Abstract][Full Text] [Related]
17. Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions.
Thanaraj TA; Clark F
Nucleic Acids Res; 2001 Jun; 29(12):2581-93. PubMed ID: 11410667
[TBL] [Abstract][Full Text] [Related]
18. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
Hennig EE; Conney AH; Wei SJ
Cancer Res; 1995 Apr; 55(7):1550-8. PubMed ID: 7882364
[TBL] [Abstract][Full Text] [Related]
19. Splicing of 5' introns dictates alternative splice selection of acetylcholinesterase pre-mRNA and specific expression during myogenesis.
Luo ZD; Camp S; Mutero A; Taylor P
J Biol Chem; 1998 Oct; 273(43):28486-95. PubMed ID: 9774478
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH)-releasing hormone increases the expression of the dominant-negative GH isoform in cases of isolated GH deficiency due to GH splice-site mutations.
Petkovic V; Godi M; Lochmatter D; Eblé A; Flück CE; Robinson IC; Mullis PE
Endocrinology; 2010 Jun; 151(6):2650-8. PubMed ID: 20351314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
